BlackBarn Capital Partners LP In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), BlackBarn Capital Partners LP reported 15 stock positions worth $254.1 million . Its top holding was Roivant Sciences (ROIV) at 19.2% of the portfolio, followed by Unitedhealth (UNH, 11.9% ) and Molina Healthcare (MOH, 11.1% ). Compared with Q3 2024, it opened 2 new positions, sold out of 5, added to 10 and reduced 1. The biggest buy was Unitedhealth (UNH, shares +133% ) and the biggest sale an exit from AT&T (T).
Location NEW YORK, NY
CIK 0002010204
Portfolio Value $254.1M (Q4 2024) Holdings 15 stocks · $254.1M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q3 2024 ROIV Roivant Sciences Ltd. 4,125,000 $48.8M Add +3.1% UNH Unitedhealth Group Inc. 60,000 $30.4M Add +133.5% MOH Molina Healthcare Inc. 97,000 $28.2M Add +61.7% TEVA Teva Pharmaceutical-SP ADR 1,050,000 $23.1M Add +107.1% AMRX Amneal Pharmaceuticals Inc. 2,850,000 $22.6M Add +18.2% CIVI Civitas Resources Inc. 380,000 $17.4M Add +52.0% CHRD Chord Energy Corp. 140,000 $16.4M Add +75.0% DHC Diversified Healthcare Trust 6,250,000 $14.4M Add +41.8% BRBS Blue Ridge Bankshares Inc. 4,366,262 $14.1M Reduce -7.2% PRVA Privia Health Group Inc. 663,397 $13.0M Add +65.8% BVFL BV Financial Inc. filed as BV FINL INC 480,000 $8.3M No change ABUS Arbutus Biopharma Corp. 2,341,871 $7.7M Add +13.1% FBLA FB Bancorp Inc. 400,000 $4.8M New ACLS Axcelis Technologies Inc. 55,997 $3.9M New MODVQ Modivcare Inc. 100,577 $1.2M No change
Options reported separately and not counted above: SPY puts ($1.5B), TSLA puts ($101.0M).
Portfolio Sells Q3 2024 → Q4 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▲ T AT&T Inc. Sold out 0.00% −7.17 ELV Elevance Health Inc. Sold out 0.00% −5.08 LW Lamb Weston Holdings Inc. Sold out 0.00% −2.46 TCBX Third Coast Bancshares Inc. Sold out 0.00% −2.27 BCBP BCB Bancorp Inc. Sold out 0.00% −0.51 BRBS Blue Ridge Bankshares Inc. Reduce -7.2% 5.53% −0.19
Portfolio Buys Q3 2024 → Q4 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q3 2024 % Of Portfolio Change To Portfolio ▼ UNH Unitedhealth Group Inc. Add +133.5% 11.95% +5.41 TEVA Teva Pharmaceutical-SP ADR Add +107.1% 9.11% +5.14 MOH Molina Healthcare Inc. Add +61.7% 11.11% +2.13 PRVA Privia Health Group Inc. Add +65.8% 5.10% +1.94 CHRD Chord Energy Corp. Add +75.0% 6.44% +1.91 FBLA FB Bancorp Inc. New 1.88% +1.88 ACLS Axcelis Technologies Inc. New 1.54% +1.54 CIVI Civitas Resources Inc. Add +52.0% 6.86% +1.35 AMRX Amneal Pharmaceuticals Inc. Add +18.2% 8.88% +0.16 ABUS Arbutus Biopharma Corp. Add +13.1% 3.01% −0.45 ROIV Roivant Sciences Ltd. Add +3.1% 19.20% −0.86 DHC Diversified Healthcare Trust Add +41.8% 5.66% −2.37
Options Activity Q3 2024 → Q4 2024 Security Type Change vs Q3 2024 Underlying Shares Value ▼ SPY SS SPDR S&P 500 ETF Trust-US put Add +400.0% 2,500,000 $1.5B QQQ Invesco QQQ Trust Series 1 put Sold out 500,000 $244.0Mbefore exit TSLA Tesla Inc. put New 250,000 $101.0M
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 17 $402.2M ROIV, PRVA, DHC, NEE, NIQ Q1 2026 14 $332.4M ROIV, VECO, PRVA, DHC, NEE Q4 2025 11 $278.9M ROIV, DHC, PRVA, NIQ, NEE Q3 2025 15 $306.4M ROIV, PRVA, DHC, NXT, AMRX Q2 2025 20 $301.8M ROIV, AMRX, ACLS, DHC, MOH Q1 2025 18 $292.8M ROIV, UNH, MOH, AMRX, ACLS Q4 2024 15 $254.1M ROIV, UNH, MOH, TEVA, AMRX Q3 2024 18 $230.1M ROIV, MOH, AMRX, DHC, T Q2 2024 17 $194.0M ROIV, UNH, MOH, AMRX, BRBS Q1 2024 21 $173.0M ROIV, MOH, UNH, CHRD, CF